Clinical application of biomarkers for interstitial lung disease
10.3760/cma.j.cn114452-20240313-00126
- VernacularTitle:间质性肺疾病生物标志物的临床应用
- Author:
Meichen MA
1
;
Yushi JIN
1
;
Li′na WU
1
Author Information
1. 中国医科大学附属盛京医院检验科，沈阳110000
- Publication Type:Journal Article
- Keywords:
Lung diseases, interstitial;
Pulmonary interstitial fibrosis;
Idiopathic pulmonary fibrosis;
Biological markers
- From:
Chinese Journal of Laboratory Medicine
2024;47(12):1374-1385
- CountryChina
- Language:Chinese
-
Abstract:
Interstitial lung disease (ILD) is a heterogeneous disease characterized by diffuse pulmonary parenchyma, alveolar inflammation, and pulmonary fibrosis. At present, there are no ideal tools to diagnose and predict the prognosis of ILD. The application of biological markers can assist in the rapid diagnosis of the disease and guide clinical treatment decisions. Therefore, there is an urgent need for reliable, safety and feasible biomarkers to identify disease progression and treatment of interstitial lung disease, so as to achieve timely, accurate and personalized treatment for patients with interstitial lung disease.
